Six hybridoma clones producing monoclonal antibodies (MAbs) reactive with Pasteurella haemolytica Al leukotoxin were derived from mice immunized with leukotoxin excised from sodium dodecyl sulfatepolyacrylamide gels. Of the six MAbs, only one, Ltx-2, neutralized leukotoxin in a BL-3 cell cytotoxicity assay. MAb Ltx-2 blocked association of Al leukotoxin to BL-3 cells, as measured by flow cytometric analysis. The epitope recognized by Ltx-2 was localized to the carboxyl half of the native protein, between residues 450 and 939, by Western immunoblot analysis of CNBr fragments. Further analysis with leukotoxin deletion proteins indicated either that the Ltx-2-reactive epitope was localized in the carboxyl portion of the leukotoxin between amino acids 768 and 939 or that this region influences MAb recognition of the epitope. MAb Ltx-2 was tested for neutralizing activity against leukotoxin produced by P. haemolytica serotypes 1 through 12. The MAb neutralized leukotoxin produced by all of the A biotype isolates (serotypes 1, 5, 6, 7, 8, 9, and 12), with the exception of serotype A2, but did not neutralize any T biotype leukotoxin tested (T3, T4, or T10). The results indicate that MAb Ltx-2 neutralizes leukotoxin by interfering with target cell association and that the MAb-specific epitope is either not present or not critical for function in the leukotoxin produced by P. haemolytica serotypes A2, T3, T4, and T10.
The ruminant-specific leukotoxin produced by Pasteurella haemolytica Al is generally considered an important virulence determinant in the pathogenesis of bovine pneumonic pasteurellosis (1) . Acting as a Ca2"-dependent pore-former (6, 14) , the toxin is believed to promote bacterial proliferation by killing or incapacitating phagocytes (12, 19) . Moreover, leukotoxin-damaged phagocytes may contribute to the severe localized inflammatory response characteristic of this disease (34) . Natural field resistance is associated with circulating titers of neutralizing antibodies (13) , and such antibodies are detectable in lung fluids of calves protectively immunized by aerosol exposure to viable P. haemolytica Al (29) . In addition, recombinant leukotoxin has been used with measurable success as an experimental vaccine component (7) .
The leukotoxin has been cloned and sequenced (20, 25, 26) and has significant homology with a variety of potential pore-forming toxins collectively characterized as the RTX toxin family (24, 35) . Toxins in the RTX family have tandemly repeating glycine-rich sequences believed, at least for the Escherichia coli alpha-hemolysin, to serve as a functionally critical Ca2+-binding region (3, 27) . In addition, P. haemolytica leukotoxin shares with alpha-hemolysin an extended hydrophobic region containing a predicted membrane-spanning domain which is necessary to effect cytolysis (24, 30) . The carboxy-terminal amino acids, at least for the alpha-hemolysin, appear to function in secretion (11) , while the amino-terminal region appears to facilitate cytolysis, perhaps in the initial stages of host membrane insertion (37) . Binding and cytolysis appear to be separable events (9, 27) , and recent evidence indicates that lysis-defective mutant leukotoxin proteins with whole or partial deletions of the membrane-spanning region retain the capacity to bind to target cells and to competitively inhibit cytolysis by native leukotoxin (8) .
Monoclonal antibodies (MAbs) prepared against the alpha-hemolysin have helped to further define important domains within the toxin (22, 30) , including a potentially important domain between the membrane-spanning region and the repeating glycine-rich domain that contains an epitope which, when bound by antibody, results in potent neutralization (31, 37) . Similar investigations have not been performed with MAbs directed against P. haemolytica Al leukotoxin.
We report here the production of murine MAbs raised against P. haemolytica Al leukotoxin. One leukotoxinneutralizing MAb which blocked association of the leukotoxin with sensitive target cells was identified. Further evaluation revealed that the epitope recognized by the neutralizing MAb was distributed or expressed differently in leukotoxins produced by different P. haemolytica serotypes and most notably was either absent or not critical for the toxic effects of leukotoxins from T biotypes and A2 serotypes. Preliminary epitope mapping indicated that the neutralizing antibody binds to a site located between residues 450 and 939 of the intact 953-residue native leukotoxin. (16) . Percent cytotoxicity was determined as the ratio of A540 in test wells with leukotoxin to A540 in control wells (16, 25) . One unit of leukotoxin is defined as the dilution of filtrate sample determined to yield 50% cytotoxicity (14) . The (18) . Briefly, concentrated Al and A2 culture filtrates were preincubated for 50 min at 4°C with 20 jig of MAb Ltx-2 in a total volume of 100 jil containing 100 U of leukotoxin. BL-3 cells (106 in 35 ,ul of PBS) were then added, and the suspension was incubated for an additional 30 min at 37°C. Following three cycles of low-speed centrifugation and washing with cold PBS containing 3% BSA and 0.02% sodium azide, the cells were treated with rabbit antileukotoxin antibody for 1 h at 4°C and washed three times as described above. To detect cell-bound rabbit antileukotoxin antibodies, the cells were treated with fluorescein-conjugated donkey anti-rabbit immunoglobulin antibody (Jackson Laboratories, West Grove, Pa.). After a wash, single-color fluorescence analysis was performed with a FACScan fluorescence-activated cell sorter (Becton Dickinson, San Jose, Calif.).
MATERIALS AND METHODS

Bacteria
Plasmid manipulations. Plasmids containing internal deletions of the lktA gene were derived from pYFC19 (4, 8) (Fig. 1) ; however, only Ltx-2, an IgGl MAb, displayed neutralizing activity for the leukotoxin. With sensitive BL-3 target cells, Ltx-2 effected 50% neutralization of 3 and 1 U of leukotoxin activity at 300 and 30 ng/ml, respectively (Fig. 2) .
Epitope distribution among serotype leukotoxins. Leukotoxin production is a characteristic of all P. haemolytica serotypes (21, 32) . Therefore, MAb Ltx-2 was tested for neutralization of the leukotoxin produced by other P. haemolytica serotypes. Culture filtrates from isolates representing serotypes 1 through 12 were adjusted to 1 and 4 U and incubated with Ltx-2 at 25 ,ug/ml, a concentration of the antibody at least 100-fold greater than required to neutralize 3 U of Al toxin (Fig. 2) . The results are given in Table 1 . MAb Ltx-2 neutralized leukotoxic activity derived from serotypes 1, 5, 6, 7, 8, 9 , and 12 at both 4 and 1 U. However, the MAb did not neutralize the leukotoxic activity produced by serotypes 2, 3, 4, and 10. All of the leukotoxins neutralized were produced by serotypes of biotype A (serotypes 1, Further testing of MAb Ltx-2 revealed that the MAb did not react by ELISA with A2 P. haemolytica leukotoxin and reacted too faintly in the Western immunoblot for photographic reproduction. In addition, when Ltx-2 reactivity with T3, T4, and T10 leukotoxins was assessed by Western immunoblot, reactivity was detected only with the T10 leukotoxin band (not shown).
Effect of MAb Ltx-2 on leukotoxin-target cell interaction. MAb Ltx-2 could effect toxin neutralization either by influencing a critical function or site involved in pore formation or by preventing association of the toxin with the target cell. Flow cytometry was performed to determine whether Ltx-2 acted to block the association of Al leukotoxin with the BL-3 cells. Leukotoxin was incubated with and without Ltx-2 and then added to the target cells. Leukotoxin associated with the target cells was detected by adding rabbit antisera raised against electrophoretically purified leukotoxin followed by fluorescein isothiocyanate-labeled anti- rabbit immunoglobulin antisera. Preincubation of leukotoxin with MAb Ltx-2 blocked its association with the target cells (Fig. 3A) . Fifty percent of the BL-3 cells were positive for bound leukotoxin. Preincubation of the toxin with Ltx-2 reduced this percentage to essentially 0, which was not different from the FITC-labeled control. As an additional control, the same experiment was performed with A2 leukotoxin. The detecting rabbit anti-Al leukotoxin antiserum effectively neutralized A2 leukotoxin in addition to Al (not shown). MAb Ltx-2 did not prevent the association of A2 leukotoxin with BL-3 cells (Fig. 3B) . Without Ltx-2, 52% of the BL-3 cells were positive for bound A2 leukotoxin. Preincubation of the toxin with Ltx-2 did not reduce this value; approximately 60% of the cells were positive for bound A2 leukotoxin. Thus, Al leukotoxin, which is neutralized by the MAb, was prevented from associating with the target cells, while the MAb did not prevent the binding of or neutralize the A2 leukotoxin.
Preliminary epitope mapping. CNBr cleavage fragments and mutant deletion proteins of the leukotoxin were used to provide preliminary generalized localization of the epitope recognized by MAb Ltx-2. The native leukotoxin contains five methionine residues at amino acid positions 1, 156, 408, 449, and 939 (26) . Following complete CNBr cleavage, only one band was detected by immunoblot after SDS-PAGE. This band migrated at about 50 kDa, approximately the mass of an expected 490-amino-acid cleavage fragment containing amino acids 450 to 939 (Fig. 4) .
The derivatives of pYFC19 with deletions of the lktA4 gene are presented in Fig. 5 . These mutated genes in the E. coli host, TBl, produced truncated proteins with deletions across virtually the entire protein. MAb Ltx-2 immunoblots of SDS-PAGE gels of 10% TCA-precipitated intact cells revealed single bands for all the truncated proteins except pWC64, which had a deletion of the carboxy terminus beginning at amino acid 768. Although not shown in the immunoblot (Fig. 4) , this truncated protein was visualized by both rabbit and bovine antileukotoxin antisera (8) and was detectable by India ink stain. The weakly stained band for pDS25 was also weakly visualized by rabbit and bovine antileukotoxin antisera, indicating lesser production of this mutant protein.
Results with the deletion proteins confirmed the CNBr localization of Ltx-2 reactivity within the carboxyl half of the native protein and suggested possible localization of an epitope between amino acids 768 and 939. However, this indirect approach was not definitive, and the possibility of multiple epitopes between amino acids 450 and 768, whose (12, 15) . Again, definite proof will require testing of additional A2 isolates and eventual cloning and sequencing of A2 1ktA; however, this observation is suggestive of sequence or conformational differences between Al and A2 leukotoxin as well as between A and T leukotoxin. This potential difference is further strengthened by the failure of additional Al-derived MAbs to react with A2 leukotoxin. By ELISA, only one of the nonneutralizing MAbs, Ltx-81, clearly reacted with the A2 leukotoxin. Although the majority of nonneutralizing MAbs reacted with denatured A2 leukotoxin by Western blot analysis, MAb Ltx-35 failed to react even under these conditions. Thus, at least two Al epitopes could not be definitively detected in A2 leukotoxin.
The nature of the epitope recognized by MAb Ltx-2 is unclear. The MAb reacted weakly with toxin that had been affixed to ELISA wells in alkaline carbonate buffer. Ltx-2, however, was a very potent neutralizer of soluble toxin, and although the titration is not presented in the Results section, Ltx-2 reacted very well by ELISA when the leukotoxin was trapped by other toxin-specific MAbs. Apparently, the epitope recognized by the MAb is more accessible when the leukotoxin is in soluble form rather than affixed directly to the ELISA well. Recognition of the epitope by immunoblot following the denaturing conditions of SDS-PAGE suggests that the epitope is continuous rather than discontinuous.
The mechanism by which the leukotoxin associates with target cell membranes has not been elucidated. The Ca2+-binding glycine-rich repeat domain is critical for RTX toxin effects and has been proposed to function in binding (24, 27) . However, it remains unclear whether this requirement is important in initial recognition or at a secondary stage. Regardless, binding and pore formation appear to be separable events (9, 27) , and evidence reported by Cruz et al. (8) indicates that the binding functions are distinct from the lytic functions of Al leukotoxin. Mutant toxins with whole or partial deletions of the putative membrane-spanning regions agglutinated BL-3 cells and, in addition, were antagonistic for cell lysis by native leukotoxin. In the present study, MAb Ltx-2 prevented the leukotoxin from associating with the target cells, as measured by flow cytometry, suggesting that the MAb neutralizes the toxin by preventing its initial association with the target cell membrane. Thus, the MAb may react with an epitope associated with the binding domain of the leukotoxin. Conversely, Ltx-2 binding may prevent association of the leukotoxin by interfering with transitional-state changes or even by enhancing leukotoxin inactivation. The correct interpretation obviously will require further investigation; however, it is interesting that preliminary mapping positions the epitope in an amino acid sequence devoid of potential membrane-spanning regions but containing at least the last two repeats in the glycine-rich repeat domain. Work is in progress to localize this potentially important epitope more precisely.
